JPRN-UMIN000014186已完成未知
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertension - Eplerenone study
Jichi Medical University School of Medicine0 个研究点目标入组 100 人开始时间: 2014年6月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Diabetes with albuminuria or proteinuria 2.Allergy, or allergic reaction to study drugs 3. Patients with Hyperkalemia or serum potassium level>5.0mEq/ 4.Renal dysfunction (Ccr<50ml/min) 5.Sevre Hepatic damage 6.Taking potassium, or spironolactone 7.Taking Itraconazole, Ritonavir, and Nelfinavir 8. age<20yrs, or dementia 9. Not appropriate for the study.
研究者
相似试验
已完成
2 期
Effects of mineralocorticoid receptor antagonist on intradialytic hypertension: a multicenter, double-blind, randomized crossover studyIntradialytic hypertensionSpironolactoneMineralocorticoid receptor antagonistTCTR20200604013ampang hospital49
已完成
不适用
Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000037657Tokyo Women's Medical University Hospital100
已完成
2 期
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover studyIntradialytic hypotensionMineralocorticoid receptor agonistTCTR20200128004ampang hospital10
进行中（未招募）
1 期
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors?depressed patients and healthy control subjectsEUCTR2014-005239-15-DECharité - Universitätsmedizin Berlin232
已完成
不适用
Effect of spironolactone on ischemia reperfusion injury in renal transplant recipientsIschemia reperfusion injuryCirculatory SystemISRCTN01577227Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)60